To briefly summarize, the attribution methodology that identifies a clinician-patient care relationship for these chronic condition episode-based measures is slightly different at the clinician group and individual MIPS eligible clinician levels, to reflect that care provided at the clinician group and individual MIPS eligible clinician levels, respectively
As used in this subpart, the following definitions apply: Currently in shortage means that at least one NDC-10 assigned to the billing and payment code of a Part B rebatable drug with the status currently in shortage is on a shortage list maintained by the FDA under section 506E of the FD&C Act
We are proposing a price of $32.50 for the supply input that describes a 65mg capsule of Opfolda (supply code SH111)
and reduced the Shared Savings Program quality measure set from 31 to 23 measures (83 FR 59940 through 59990 and 59707 through 59715)
For an ACO that reports the three eCQMs/MIPS CQMs/Medicare CQMs in the APP quality measure set, meeting the data completeness requirement at 414.1340 of this subchapter for all three eCQMs/MIPS CQMs/Medicare CQMs, and administers the CAHPS for MIPS survey (except as specified in 414.1380(b)(1)(vii)(B) of this subchapter), CMS calculates the ACO's health equity adjusted quality performance score as the sum of the ACO's MIPS Quality performance category score for all measures in the APP quality measure set and the ACO's health equity adjustment bonus points calculated in accordance with paragraph (b)(4) of this section
